Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-14-011796
Filing Date
2014-06-24
Accepted
2014-06-24 17:21:51
Documents
1
Period of Report
2014-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 JUNE 20, 2014 rdgdoc.html 3  
1 FORM 3 JUNE 20, 2014 rdgdoc.xml 3 1529
  Complete submission text file 0001437749-14-011796.txt   3111
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Issuer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELSION CORPORATION 997 LENOX DRVIE, SUITE 100 LAWRENCEVILLE NJ 08648
Business Address
Anwer Khursheed (Reporting) CIK: 0001611756 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15911 | Film No.: 14938214